Belzutifan versus everolimus for previously treated advanced clear cell renal cell carcinoma: Subgroup analysis of the phase 3 LITESPARK-005 study

Basit Öğe Kaydı
dc.contributor.authorAlbiges, Laurence
dc.contributor.authorChoueiri, Toni K.
dc.contributor.authorPeltola, Katriina
dc.contributor.authorde Velasco, Guillermo
dc.contributor.authorBurotto, Mauricio
dc.contributor.authorSuarez, Cristina
dc.contributor.authorGhatalia, Pooja
dc.date.accessioned2025-05-10T19:38:44Z
dc.date.issued2024
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstract[No abstract available]
dc.identifier.doi10.1093/oncolo/oyae181.005
dc.identifier.endpageS4
dc.identifier.issn1083-7159
dc.identifier.issn1549-490X
dc.identifier.scopusqualityQ1
dc.identifier.startpageS3
dc.identifier.urihttps://doi.org/10.1093/oncolo/oyae181.005
dc.identifier.urihttps://hdl.handle.net/20.500.14730/9457
dc.identifier.volume29
dc.identifier.wosWOS:001289325400029
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherOxford Univ Press
dc.relation.ispartofOncologist
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectbelzutifan
dc.subjectHIF-2 alpha
dc.subjectrenal cell carcinoma
dc.titleBelzutifan versus everolimus for previously treated advanced clear cell renal cell carcinoma: Subgroup analysis of the phase 3 LITESPARK-005 study
dc.typeConference Object

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
9457.pdf
Boyut:
480.52 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu